CLASS II Drug recall · Reported 22 Jan 2020 · FDA Enforcement Report
Yeast Arrest, Homeopathic Formula, Vaginal Support suppositories recalled
Wisconsin Pharmacal is recalling Yeast Arrest, Homeopathic Formula, Vaginal Support suppositories, distributed in Oregon. The recall was initiated on 14 Nov 2019 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0781-2020
- FDA event ID
- 84291
- Recalling firm
- Wisconsin Pharmacal, Jackson, WI
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 14 Nov 2019
- FDA classified
- 16 Jan 2020
- Reported
- 22 Jan 2020
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Manufacturing (CGMP) Deviations
Timeline
| 14 Nov 2019 | Recall initiated by company | |
| 16 Jan 2020 | Classified by FDA | +63 days |
| 22 Jan 2020 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
cGMP violations
Product as listed by the FDA
Yeast Arrest, Homeopathic Formula, Vaginal Support suppositories, packaged in a) 14-count carton (NDC 68093-0730-1 and 68093-0730-3), b) 28-count carton (NDC 68093-0730-2 and 68093-0730-4), Manufactured for: Vitanica, 12401 SW Leveton Drive, Tualatin, OR 97062.
Where it was distributed
OR
Questions about this recall
Why was it recalled?
cGMP violations
Which lots are affected?
Lot #: a) 81827, Exp 8/2020; 111872, Exp 11/2020; 41970, Exp 4/2021; 519104, Exp 5/2021; b) 81827, Exp 8/2020; 111872, Exp 11/2020; 41970, Exp 4/2021.
Where was it sold?
OR
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Wisconsin Pharmacal
All 3| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | MG217 Multi-Symptom Treatment Cream & Skin Protectant recalled | Wisconsin Pharmacal | Other Bacterial Contamination | Nationwide |
| Drug | CLASS II | CVS pharmacy, Pain Relieving Antiseptic Spray recalled | Wisconsin Pharmacal | Sterility | Nationwide |